ConductScience.org, home

Paper2199202

The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels.

Batch J and 6 others. Eur J Clin Pharmacol, 1990. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels. Papers, record 2199202. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2199202

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.78
iCite
Revised in PubMed
2019-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Batch JJ
2Ma AA
3Bird DD
4Noble RR
5Charles BB
6Ravenscroft PP
7Cameron DD

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood GlucoseMajor topic
C-PeptideMajor topic
GliclazideMajor topic
InsulinMajor topic
Sulfonylurea CompoundsMajor topic
Aged
Diabetes Mellitus, Type 2
Female
Food
Humans
Male
Middle Aged
Time Factors

Source PubMed

Download CSV of topics

References12

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13882491Gliclazide therapy is associated with potentiation of postbinding insulin action in obese, non-insulin-dependent diabetic subjects.Diabetes1985https://conductscience.org/library/papers/3882491PubMed
2345754Effects of glipizide and food intake on the blood levels of glucose and insulin in diabetic patients.Acta Med Scand1978https://conductscience.org/library/papers/345754PubMed
36749526The effect of food on the bioavailability and pharmacodynamics of tolbutamide in diabetic patients.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/6749526PubMed
47449114Observations on comparisons of within-run and day-to-day precision.Clin Chem1981https://conductscience.org/library/papers/7449114PubMed
56804245Improved effect of glibenclamide on administration before breakfast.Eur J Clin Pharmacol1982https://conductscience.org/library/papers/6804245PubMed
66995130Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/6995130PubMed
76767639Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide.Diabetologia1980https://conductscience.org/library/papers/6767639PubMed
82669710The effects of long term gliclazide administration on insulin secretion and insulin sensitivity.Aust N Z J Med1989https://conductscience.org/library/papers/2669710PubMed
97002565Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects.Eur J Clin Pharmacol1980https://conductscience.org/library/papers/7002565PubMed
106488522Measurement of gliclazide in plasma by radial compression reversed-phase liquid chromatography.Clin Chem1984https://conductscience.org/library/papers/6488522PubMed
113289994Physiological importance of deficiency in early prandial insulin secretion in non-insulin-dependent diabetes.Diabetes1988https://conductscience.org/library/papers/3289994PubMed
126487510Improved effect of tolbutamide when given before food in patients on long-term therapy.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6487510PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
31758056Fabrication of Second Generation Smarter PLGA Based Nanocrystal Carriers for Improvement of Drug Delivery and Therapeutic Efficacy of Gliclazide in Type-2 Diabetes Rat Model.Sci Rep2019https://conductscience.org/library/papers/31758056PubMed
10718777Pharmacokinetics and pharmacodynamics of gliclazide in Caucasians and Australian Aborigines with type 2 diabetes.Br J Clin Pharmacol2000https://conductscience.org/library/papers/10718777PubMed
7691511Gliclazide. An update of its pharmacological properties and therapeutic efficacy in non-insulin-dependent diabetes mellitus.Drugs1993https://conductscience.org/library/papers/7691511PubMed
1623912Effect of magnesium hydroxide on the absorption and efficacy of tolbutamide and chlorpropamide.Eur J Clin Pharmacol1992https://conductscience.org/library/papers/1623912PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
INS3630PubTator's text mininghttps://conductscience.org/library/genes/3630

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2199202

GET https://conductscience.org/api/papers/v1/2199202/authors